» Articles » PMID: 29470501

Tissue-specific and Mosaic Imprinting Defects Underlie Opposite Congenital Growth Disorders in Mice

Abstract

Differential DNA methylation defects of H19/IGF2 are associated with congenital growth disorders characterized by opposite clinical pictures. Due to structural differences between human and mouse, the mechanisms by which mutations of the H19/IGF2 Imprinting Control region (IC1) result in these diseases are undefined. To address this issue, we previously generated a mouse line carrying a humanized IC1 (hIC1) and now replaced the wildtype with a mutant IC1 identified in the overgrowth-associated Beckwith-Wiedemann syndrome. The new humanized mouse line shows pre/post-natal overgrowth on maternal transmission and pre/post-natal undergrowth on paternal transmission of the mutation. The mutant hIC1 acquires abnormal methylation during development causing opposite H19/Igf2 imprinting defects on maternal and paternal chromosomes. Differential and possibly mosaic Igf2 expression and imprinting is associated with asymmetric growth of bilateral organs. Furthermore, tissue-specific imprinting defects result in deficient liver- and placenta-derived Igf2 on paternal transmission and excessive Igf2 in peripheral tissues on maternal transmission, providing a possible molecular explanation for imprinting-associated and phenotypically contrasting growth disorders.

Citing Articles

Identification of responsible sequences which mutations cause maternal H19-ICR hypermethylation with Beckwith-Wiedemann syndrome-like overgrowth.

Hara S, Matsuhisa F, Kitajima S, Yatsuki H, Kubiura-Ichimaru M, Higashimoto K Commun Biol. 2024; 7(1):1605.

PMID: 39623082 PMC: 11612015. DOI: 10.1038/s42003-024-07323-x.


Dysregulated expression disrupts cardiac-placental axis during development of Silver-Russell syndrome-like mouse models.

Chang S, Fulmer D, Hur S, Thorvaldsen J, Li L, Lan Y Elife. 2022; 11.

PMID: 36441651 PMC: 9704805. DOI: 10.7554/eLife.78754.


The Role of Non-Coding RNAs in the Human Placenta.

Zarkovic M, Hufsky F, Markert U, Marz M Cells. 2022; 11(9).

PMID: 35563893 PMC: 9104507. DOI: 10.3390/cells11091588.


Exerts Maternal and Sexually Dimorphic Effects on Genomic Imprinting.

Xu Z, Shi J, Zhang Y, Liu Y, Zhao J, Chen Q Front Cell Dev Biol. 2022; 10:784128.

PMID: 35252168 PMC: 8895500. DOI: 10.3389/fcell.2022.784128.


The number of the CTCF binding sites of the H19/IGF2:IG-DMR correlates with DNA methylation and expression imprinting in a humanized mouse model.

Freschi A, Del Prete R, Pignata L, Cecere F, Manfrevola F, Mattia M Hum Mol Genet. 2021; 30(16):1509-1520.

PMID: 34132339 PMC: 8330897. DOI: 10.1093/hmg/ddab132.


References
1.
Nagy A . Cre recombinase: the universal reagent for genome tailoring. Genesis. 2000; 26(2):99-109. View

2.
Leighton P, Saam J, Ingram R, Stewart C, Tilghman S . An enhancer deletion affects both H19 and Igf2 expression. Genes Dev. 1995; 9(17):2079-89. DOI: 10.1101/gad.9.17.2079. View

3.
Weyrich A . Preparation of genomic DNA from mammalian sperm. Curr Protoc Mol Biol. 2012; Chapter 2:Unit 2.13.1-3. DOI: 10.1002/0471142727.mb0213s98. View

4.
Demars J, Shmela M, Rossignol S, Okabe J, Netchine I, Azzi S . Analysis of the IGF2/H19 imprinting control region uncovers new genetic defects, including mutations of OCT-binding sequences, in patients with 11p15 fetal growth disorders. Hum Mol Genet. 2009; 19(5):803-14. DOI: 10.1093/hmg/ddp549. View

5.
Schoenherr C, Levorse J, Tilghman S . CTCF maintains differential methylation at the Igf2/H19 locus. Nat Genet. 2002; 33(1):66-9. DOI: 10.1038/ng1057. View